(Q39752079)

14 September 2017

1 reference

title

A decade of developments in diuretic drug therapy (English)

1 reference

14 September 2017

Hutcheon DE

1

1 reference

14 September 2017

Martinez JC

series ordinal

2

1 reference

14 September 2017

publication date

1 November 1986

1 reference

The Journal of Clinical Pharmacology

14 September 2017

published in

1 reference

14 September 2017

volume

26

1 reference

14 September 2017

issue

8

1 reference

14 September 2017

page(s)

567-579

1 reference

Bumetanide and frusemide: a comparison of dose-response curves in healthy men.

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Clinical efficacy and safety of indapamide in essential hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Studies on the mechanism and characteristics of action of a uricosuric diuretic, indacrinone (MK-196).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

(Acylaryloxy)acetic acid diuretics. 2. (2-Alkyl-2-aryl-1-oxo-5-indanyloxy)acetic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Pharmacology of Bay g 2821, a long-acting, high-ceiling diuretic

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Comparison of the pharmacodynamic effect of muzolimine and furosemide in patients with advanced chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Pharmacokinetics of hydrochlorothiazide in patients with congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Absolute bioavailability of chlorthalidone in man: A cross-over study after intravenous and oral administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Fate of [14C]-bumetanide in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Piretanide. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Effect of probenecid on the natriuresis and renin release induced by bumetanide in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Effects of probenecid on furosemide kinetics and natriuresis in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Renal Tubular Chloride Transport and the Mode of Action of Some Diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Effect of bumetanide and furosemide on the thick ascending limb of Henle's loop of rabbits and rats perfused in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Effect of "high ceiling" diuretics on active salt transport in the cortical thick ascending limb of Henle's loop of rabbit kidney. Correlation of chemical structure and inhibitory potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Activity of a new high efficiency diuretic in man: piretanide (HOE 118).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Tubular action of diuretics: distal effects on electrolyte transport and acidification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Acute effects of piretanide in normal subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Comparison of Bumetanide and Hydrochlorothiazide on Renal Potassium and Hydrogen Ion Excretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Renal actions of piretanide and three other "loop" diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

On the mechanism of lithium-induced diabetes insipidus in man and the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Prevention of calcium stones with thiazides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

A comparison of the effect of frusemide and bumetanide on the diuretic response and fibrinolytic mechanism in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Control of renin secretion in the dog. Effects of furosemide on the vascular and macula densa receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Natriuresis and renin release by the denervated dog kidney during furosemide administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Control of renin release. Effects of d-propranolol and renal denervation on furosemide-induced renin release in the dog.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Inhibition of the renin-aldosterone response to furosemide by indomethacin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Effect of bumetanide, frusemide and prostaglandin E2 on the isolated perfused kidney of rat and rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Contribution of prostaglandins to the systemic and renal vascular response to frusemide in normal man

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Mechanisms of hemodynamic actions of furosemide: differentiation of vascular and renal effects on blood pressure in functionally anephric hypertensive patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Comparative Efficacy and Safety of Bumetanide and Furosemide in Long‐Term Treatment of Edema Due to Congestive Heart Failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

The urinary sodium: potassium ratio and response to diuretics in resistant oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Hemodynamic trial of sequential treatment with diuretic, vasodilator, and positive inotropic drugs in left ventricular failure following acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

The role of furosemide alone and in combination with digoxin in the relief of symptoms of congestive heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Acute haemodynamic effects of a single intravenous dose of piretanide in congestive heart failure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Effect of diuresis on the performance of the failing left ventricle in man.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Effect of furosemide on hemodynamics and lung water in acute pulmonary edema secondary to myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Kinetic disposition and diuretic effect of frusemide in acute pulmonary oedema

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Long-term bumetanide treatment of patients with edema due to renal disease. Cooperative studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Oral piretanide in chronic renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Diuretic action of bumetanide in advanced chronic renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Furosemide kinetics in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Furosemide-induced adverse reactions in cirrhosis of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Characterization of the renin-aldosterone system in decompensated cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Treatment of fluid retention in cirrhosis: a comparison of bumetanide and frusemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Spironolactone-Induced Hyperchloremic Acidosis in Cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

The effects of a single, intravenous dose of bumetanide versus furosemide in patients with ascites and edema due to alcoholic liver disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

The pharmacokinetics and pharmacodynamics of the diuretic bumetanide in hepatic and renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Dose response to chlorthalidone in patients with mild hypertension; Efficacy of a lower dose

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Diuretic-induced ventricular ectopic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Diuretic-induced hypokalemia in uncomplicated systemic hypertension: effect of plasma potassium correction on cardiac arrhythmias

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Thiazides, beta blockers and lipoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Serum triglycerides and serum uric acid in untreated and thiazide-treated patients with mild hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Changes in the fasting blood sugar after hydrochlorothiazide and potassium supplementation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Frusemide-induced pancreatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Bumetanide-induced hyperamylaseaemia in patients with renal insufficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Comparison of Adverse Reactions to Bumetanide and Furosemide

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Letter: Lithium poisoning precipitated by diuretics

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Adjustment of lithium dose during lithium-chlorothiazide therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Serum lithium levels and long-term diuretic use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Triamterene-induced nephrolithiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

Excretion of triamterene and its metabolite in triamterene stone patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FJ.1552-4604.1986.TB02951.X

10.1002/J.1552-4604.1986.TB02951.X

21 January 2018

Identifiers

DOI

1 reference

14 September 2017

1 reference